Trial Profile
Early statin treatment in patients with acute coronary syndrome: The best intensive LDL-cholesterol lowering therapy is sought by two different regimens during half a year treatment using Volumetric Intravascular Ultrasound Analysis
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 17 May 2016
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; Pitavastatin (Primary)
- Indications Acute coronary syndromes; Coronary artery disease
- Focus Biomarker; Therapeutic Use
- Acronyms ESTABLISH-2
- 13 Sep 2012 Status changed from suspended to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 04 Nov 2011 New trial record